Literature DB >> 16195537

CD4+ cells play a limited role in murine lung infection with Mycobacterium kansasii.

Catharina W Wieland1, Sandrine Florquin, Jennie M Pater, Sebastiaan Weijer, Tom van der Poll.   

Abstract

Mycobacterium kansasii has emerged as an important nontuberculous mycobacterium that can cause severe infection in the immunocompromised host, especially in human immunodeficiency virus-infected patients. However, little is known about the pathogenesis of this infection. Because patients suffering from M. kansasii infection are severely compromised in their cellular immune response, we studied the course of infection in CD4+ cell knockout (KO) mice. Wild-type (WT) mice and CD4+ KO mice were infected with 10(5) cfu of M. kansasii. Although previously shown to be susceptible to Mycobacterium tuberculosis infection, CD4+ KO mice demonstrated no impairment in clearing infection with M. kansasii when compared with WT animals, despite reduced pulmonary inflammation (reduced granuloma formation and lymphocyte infiltration in the lungs). Pulmonary IFN-gamma levels and M. kansasii-induced IFN-gamma production by splenocytes from infected animals were reduced in CD4+ KO mice, confirming that these mice were defective in the M. kansasii-specific T helper cell type 1 immune response. Furthermore, mice deficient for IFN-gamma, IL-12p35, IL-12p40, or IL-18 also displayed a normal host defense against pulmonary infection with M. kansasii. These data suggest that CD4+ cells, IFN-gamma, and an intact T helper cell type 1 response play a limited role in protective immunity against pulmonary M. kansasii infection.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16195537     DOI: 10.1165/rcmb.2005-0198OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  3 in total

1.  CD14 contributes to pulmonary inflammation and mortality during murine tuberculosis.

Authors:  Catharina W Wieland; Gerritje J W van der Windt; W Joost Wiersinga; Sandrine Florquin; Tom van der Poll
Journal:  Immunology       Date:  2008-04-03       Impact factor: 7.397

2.  Activation of an NLRP3 inflammasome restricts Mycobacterium kansasii infection.

Authors:  Chang-Chieh Chen; Sheng-Hui Tsai; Chia-Chen Lu; Shiau-Ting Hu; Ting-Shu Wu; Tsung-Teng Huang; Najwane Saïd-Sadier; David M Ojcius; Hsin-Chih Lai
Journal:  PLoS One       Date:  2012-04-30       Impact factor: 3.240

3.  B Cell-Based Vaccine Transduced With ESAT6-Expressing Vaccinia Virus and Presenting α-Galactosylceramide Is a Novel Vaccine Candidate Against ESAT6-Expressing Mycobacterial Diseases.

Authors:  Bo-Eun Kwon; Jae-Hee Ahn; Eun-Kyoung Park; Hyunjin Jeong; Hyo-Ji Lee; Yu-Jin Jung; Sung Jae Shin; Hye-Sook Jeong; Jung Sik Yoo; EunKyoung Shin; Sang-Gu Yeo; Sun-Young Chang; Hyun-Jeong Ko
Journal:  Front Immunol       Date:  2019-10-29       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.